FDA Inspection
Prime PackagingPrime Packaging – FDA Inspection, Aug 1, 2025
Record Details
This FDA Inspection record concerns Prime Packaging, with an inspection on August 1, 2025, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 156bf089-237a-496b-9440-88a63a077b5c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1277276
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)Defined areas of adequate size for operations
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Prime Packaging
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 29, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 4, 2012 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
| June 8, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Prime Packaging
- FDA Inspection 1095984 - 2019-07-12
- FDA Inspection 881383 - 2014-04-29
- FDA Inspection 760406 - 2012-01-04
- FDA Inspection 594187 - 2009-06-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.